SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2 (COX-2) WITH MK-0966 (250 MGQD) IS ASSOCIATED WITH LESS GASTRODUODENAL DAMAGE THAN ASPIRIN (ASA) 650 MG QID OR IBUPROFEN (IBU) 800 MG TID

Citation
F. Lanza et al., SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2 (COX-2) WITH MK-0966 (250 MGQD) IS ASSOCIATED WITH LESS GASTRODUODENAL DAMAGE THAN ASPIRIN (ASA) 650 MG QID OR IBUPROFEN (IBU) 800 MG TID, Gastroenterology, 112(4), 1997, pp. 194-194
Citations number
NO
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
ISSN journal
00165085
Volume
112
Issue
4
Year of publication
1997
Supplement
S
Pages
194 - 194
Database
ISI
SICI code
0016-5085(1997)112:4<194:SOC(WM>2.0.ZU;2-V